KPMA asking drug prices for R&D of new drug.

Published: 2005-06-09 06:57:00

Updated: 2005-06-09 06:57:00

The local drug industries strongly called for the government's drug pricing policy more favorable and consistence to improve an industrial competitiveness by enhancing the new drug R&D, viewing the fact that the drug price margins absolutely needed in the expansion of R&D investment for the new d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK